The application of the blood-based biomarker NfL has gained considerable attention not only in the research field of neurodegenerative disorders such as multiple sclerosis [30], AD [31], or Parkinsonism disorders [32] but also in acute IS [33]. Here, NEFL is linked to Alzheimer disease.